Where does the combination of sorafenib and interferon in renal cell carcinoma stand?

Cancer. 2010 Jan 1;116(1):4-7. doi: 10.1002/cncr.24688.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzenesulfonates / administration & dosage*
  • Carcinoma, Renal Cell / drug therapy*
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • Humans
  • Interferons / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / administration & dosage*
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Sorafenib

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Interferons
  • Sorafenib
  • Receptors, Vascular Endothelial Growth Factor